BeOne Medicines (ONC) Equity Ratio (2015 - 2026)
BeOne Medicines (ONC) reported Equity Ratio of 0.56 for Q1 2026, down 7.1% year-over-year from 0.6 in Q1 2025, and up 4.5% on a QoQ basis from 0.53 in Q4 2025.
BeOne Medicines (ONC) has 12 years of Equity Ratio data on file, last reported at 0.56 in Q1 2026.
- Quarterly Equity Ratio fell 7.1% year-over-year to 0.56 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.56 (down 7.1% YoY) and the FY2025 annual result came in at 0.53, down 5.37% from the prior year.
- Equity Ratio rose to 0.56 in Q1 2026 per ONC's latest filing, from 0.53 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.8 in Q4 2022 and bottomed at 0.53 in Q4 2025.
- The 5-year median for Equity Ratio is 0.6 (2025), against an average of 0.63.
- The widest annual swing landed in 2022, when Equity Ratio grew 11.31%; it then dropped 23.81% in 2023.
- Tracing ONC's Equity Ratio over 5 years: stood at 0.8 in 2022, then dropped by 23.81% to 0.61 in 2023, then declined by 7.64% to 0.56 in 2024, then dropped by 5.37% to 0.53 in 2025, then advanced by 4.5% to 0.56 in 2026.
- Per Business Quant, the three latest ONC Equity Ratio figures stand at 0.56 (Q1 2026), 0.53 (Q4 2025), and 0.54 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 0.73 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 0.77 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 0.21 |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 0.56 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.56 |
| Dec 31, 2025 | 0.53 |
| Sep 30, 2025 | 0.54 |
| Jun 30, 2025 | 0.60 |
| Mar 31, 2025 | 0.60 |
| Dec 31, 2024 | 0.56 |
| Sep 30, 2024 | 0.59 |
| Jun 30, 2024 | 0.59 |
| Mar 31, 2024 | 0.59 |
| Dec 31, 2023 | 0.61 |
| Sep 30, 2023 | 0.68 |
| Jun 30, 2023 | 0.66 |
| Mar 31, 2023 | 0.70 |
| Dec 31, 2022 | 0.80 |
| Sep 30, 2022 | 0.69 |
| Jun 30, 2022 | 0.70 |
| Mar 31, 2022 | 0.72 |
| Dec 31, 2021 | 0.72 |
| Sep 30, 2021 | 0.64 |
| Jun 30, 2021 | 0.65 |
| Mar 31, 2021 | 0.69 |
| Dec 31, 2020 | 0.69 |
| Sep 30, 2020 | 0.77 |
| Jun 30, 2020 | 0.65 |
| Mar 31, 2020 | 0.70 |
| Dec 31, 2019 | 0.61 |
| Sep 30, 2019 | 0.69 |
| Jun 30, 2019 | 0.73 |
| Mar 31, 2019 | 0.75 |
| Dec 31, 2018 | 0.78 |
| Sep 30, 2018 | 0.82 |
| Jun 30, 2018 | 0.74 |
| Mar 31, 2018 | 0.80 |
| Dec 31, 2017 | 0.65 |
| Sep 30, 2017 | 0.72 |
| Jun 30, 2017 | 0.57 |
| Mar 31, 2017 | 0.82 |
| Dec 31, 2016 | 0.87 |
| Sep 30, 2016 | 0.80 |
| Jun 30, 2016 | 0.88 |
| Mar 31, 2016 | 0.92 |
| Dec 31, 2015 | -0.87 |